Encompass Health (NYSE:EHC) Price Target Raised to $120.00

Encompass Health (NYSE:EHC) had its price target hoisted by KeyCorp from $117.00 to $120.00 in a research note published on Monday,Benzinga reports. They currently have an overweight rating on the stock.

Several other equities research analysts have also recently weighed in on the company. Royal Bank of Canada upped their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday, February 7th. Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Finally, Truist Financial restated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Price Performance

EHC opened at $98.04 on Monday. The business has a fifty day moving average of $96.06 and a 200 day moving average of $95.43. Encompass Health has a 52-week low of $72.53 and a 52-week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market cap of $9.88 billion, a P/E ratio of 21.98, a PEG ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. As a group, sell-side analysts anticipate that Encompass Health will post 4.76 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in EHC. MassMutual Private Wealth & Trust FSB increased its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares in the last quarter. UMB Bank n.a. increased its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares in the last quarter. V Square Quantitative Management LLC increased its position in Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC acquired a new position in Encompass Health during the 3rd quarter valued at about $40,000. Finally, CBIZ Investment Advisory Services LLC increased its holdings in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.